Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Uterine Corpus Cancer AJCC v7”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Early research (Phase 1)Study completedNCT00005840
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer

Who this might be right for
Endometrial Clear Cell AdenocarcinomaEndometrial Serous AdenocarcinomaStage III Uterine Corpus Cancer+1 more
Gynecologic Oncology Group 35
Not applicableLooking for participantsNCT05334069
What this trial is testing

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more
Alliance for Clinical Trials in Oncology 2,000
Not applicableStudy completedNCT01198171
What this trial is testing

Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer

Who this might be right for
Stage I Uterine Corpus CancerStage II Uterine Corpus CancerStage III Uterine Corpus Cancer+1 more
Gynecologic Oncology Group 243
Not applicableWithdrawnNCT03902379
What this trial is testing

Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer

Who this might be right for
Endometrial CarcinomaStage 0 Fallopian Tube Cancer AJCC v7Stage I Fallopian Tube Cancer AJCC v6 and v7+53 more
Rutgers, The State University of New Jersey
Not applicableStudy completedNCT01164735
What this trial is testing

Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Who this might be right for
Recurrent Uterine Corpus CarcinomaStage III Uterine Corpus CancerStage IV Uterine Corpus Cancer
Gynecologic Oncology Group 169
Not applicableStudy completedNCT01098630
What this trial is testing

Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer

Who this might be right for
Recurrent Cervical CarcinomaRecurrent Uterine Corpus CarcinomaRecurrent Uterine Corpus Sarcoma+15 more
Gynecologic Oncology Group 778
Testing effectiveness (Phase 2)Active Not RecruitingNCT00977574
What this trial is testing

Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+7 more
National Cancer Institute (NCI) 349
Not applicableStudy completedNCT03112668
What this trial is testing

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

Who this might be right for
Malignant Female Reproductive System NeoplasmMalignant Hepatobiliary NeoplasmPartner+36 more
Rutgers, The State University of New Jersey 14
Testing effectiveness (Phase 2)Study completedNCT00006089
What this trial is testing

Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaERBB2 Gene AmplificationRecurrent Uterine Corpus Carcinoma+2 more
National Cancer Institute (NCI) 34
Early research (Phase 1)Study completedNCT01440998
What this trial is testing

Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mucinous Adenocarcinoma+13 more
National Cancer Institute (NCI) 18
Not applicableActive Not RecruitingNCT05786456
What this trial is testing

E-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study

Who this might be right for
Malignant Female Reproductive System NeoplasmStage III Cervical Cancer AJCC v8Stage III Ovarian Cancer AJCC v8+8 more
City of Hope Medical Center 23
Early research (Phase 1)Study completedNCT00410553
What this trial is testing

Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by Surgery

Who this might be right for
Adult Solid NeoplasmRecurrent Ovarian CarcinomaRecurrent Uterine Corpus Carcinoma+4 more
National Cancer Institute (NCI) 45
Not applicableStudy completedNCT01208467
What this trial is testing

Prognostic Biomarkers in Patients With Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaRecurrent Uterine Corpus CarcinomaStage I Uterine Corpus Cancer+3 more
Gynecologic Oncology Group 2,824
Early research (Phase 1)Looking for participantsNCT03968406
What this trial is testing

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

Who this might be right for
Malignant Female Reproductive System NeoplasmRecurrent Cervical CarcinomaRecurrent Endometrial Carcinoma+22 more
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+127 more
Mayo Clinic 36
Not applicableWithdrawnNCT01199250
What this trial is testing

Biomarkers in Samples From Patients With Endometrial Cancer

Who this might be right for
Lynch SyndromeRecurrent Uterine Corpus CarcinomaStage I Uterine Corpus Cancer+3 more
Gynecologic Oncology Group
Early research (Phase 1)Looking for participantsNCT05039801
What this trial is testing

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Endometrial CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Malignant Solid Neoplasm+35 more
M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)UnknownNCT00006903
What this trial is testing

Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer

Who this might be right for
Recurrent Uterine Corpus CarcinomaStage III Uterine Corpus Cancer AJCC v7Stage IV Uterine Corpus Cancer AJCC v7
Gynecologic Oncology Group 67
Early research (Phase 1)WithdrawnNCT04498520
What this trial is testing

Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+32 more
Pamela Munster
Early research (Phase 1)Active Not RecruitingNCT01970722
What this trial is testing

Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer

Who this might be right for
FIGO Stage IVA Ovarian CancerFIGO Stage IVB Ovarian CancerPlatinum-Resistant Ovarian Carcinoma+26 more
City of Hope Medical Center 40
Load More Results